IL-WEBER
18.1.2022 15:07:08 CET | Business Wire | Press release
Weber Inc. (NYSE:WEBR), the global leader in outdoor cooking innovation, technology, and products, today unveiled the first three new products in its 2022 grilling portfolio. Designed to fuse the best in smart technology, high-quality materials, performance engineering, and craftsmanship, the 2022 GENESIS Smart Gas Grill, 2022 SMOKEFIRE Wood Fired Pellet Grill, STEALTH Edition, and all-new WEBER CRAFTED Outdoor Kitchen Collection take cooking outdoors to new levels of food discovery and exploration.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220118005538/en/
“Our product lineup for the upcoming barbecue season pushes the boundaries of the types of cooking that can be done outdoors, including bringing popular methods like flat top cooking and baking right to a WEBER grill,” said Jennifer Bonuso, Senior Vice President and General Manager, Global Product Management of Weber. “These new products are shaped by insights from grilling enthusiasts around the world, who crave to create more when they cook outside. We answered that desire by bringing together our best smart technology, new features, and a unique grillware collection.”
ABOUT THE NEW WEBER CRAFTED OUTDOOR KITCHEN COLLECTION
The WEBER CRAFTED Outdoor Kitchen Collection is a line of exclusive, high-quality, interchangeable grillware that enables a variety of different cooking methods. Outdoor cooks can use traditional grill grates or switch in a flat-top surface to open up a world of new foods at the grill, like eggs, pancakes, smashed burgers, and more. Exchange the grates for a baking stone for pizzas, crispy flatbreads, and cookies, or use rotisserie skewers for kabobs and roasted chicken. The Collection transforms the grill into a versatile, complete outdoor kitchen.
The WEBER CRAFTED line features six cooking pieces -- each providing a large cooking surface -- that facilitate steaming, baking, roasting, searing, or flat top cooking right at the grill. The complete grillware Collection consists of a Dual-Sided Sear Grate, Flat Top, Glazed Baking Stone, Roasting Basket, Wok & Steamer, and Rotisserie Skewer pieces. Additionally, it includes specially designed grates and an insert that allows the grillware pieces to be easily changed out on a WEBER gas, charcoal, or pellet grill.
Each WEBER CRAFTED item is sold separately.
ABOUT THE NEW WEBER GENESIS SMART GAS GRILL
The 2022 GENESIS Smart Gas Grill, Weber’s most advanced gas grill in 15 years, creates the ultimate culinary experience for grilling enthusiasts.
Built with high-quality materials, ingenuity, and the craftsmanship Weber is known for, the 2022 GENESIS grill is feature-packed to bring a complete outdoor kitchen experience to any outside space, including:
- WEBER CRAFTED Outdoor Kitchen Collection-ready with cooking grates specially designed to accommodate the WEBER CRAFTED grate insert and grillware pieces (sold separately) and unlock a wide range of cooking options at the grill.
- Integrated WEBER CONNECT smart grilling technology creates perfectly grilled food through real-time food temperature alerts, reminders, and flip and serve notifications at the grill or on the phone. With the WEBER CONNECT App, outdoor cooks can stay connected to their grill while taking care of guests, watching the game, or enjoying a drink.
- Proprietary PUREBLU high heat burners are designed to produce the most efficient, even flame for consistent, precise heat and reliable ignition.
- Extra-large SEAR ZONE allows outdoor cooks to sear multiple food items simultaneously.
- Extra-large Prep and Serve Table accommodates more trays and dishes than previous GENESIS models.
- NIGHTVISION motion-sensor, under-the-lid LED lights illuminate the entire grilling surface - from the side table to the grates. This patent-pending lighting system is ideal for early morning, dusk, and nighttime outdoor cooking.
- Expandable, Top Cooking Grate increases the overall available grilling space of the 2022 GENESIS grill, providing extra room to cook appetizers, sides, or main course dishes, all at the same time.
The 2022 GENESIS gas grill line includes several different three and four-burner models. In addition, models are available in porcelain-enamel or stainless steel finishes.
ABOUT THE NEW SMOKEFIRE WOOD PELLET GRILL, STEALTH EDITION
The 2022 SMOKEFIRE Wood Fired Pellet Grill, STEALTH Edition, brings a sleek, distinctive black-on-black aesthetic to Weber’s all-in-one SMOKEFIRE pellet grilling experience, which centers on exceptional wood fired flavor through both high heat searing and low and slow smoking,
The 2022 SMOKEFIRE Grill, STEALTH Edition, includes:
- All-black exterior styling.
- WEBER CRAFTED Outdoor Kitchen Collection - ready to open up the types of meals that can be made on a pellet grill, adding the ability to roast, steam, and even stir-fry.
- WEBER CONNECT smart grilling technology
- Built-in grill lighting illuminates the cooking grate for those extended evening or early morning cooks.
- A top cooking grate provides a large, second level of grilling capacity.
- Porcelain-enamel construction retains heat, even in cooler temperatures, and helps prevent rust and cracking.
The 2022 SMOKEFIRE Wood Fire Pellet Grill, STEALTH Edition series includes two models. Available models will vary by geographic region.
And to help inspire mealtime, Weber recently updated its popular WEBER CONNECT App with recipes, recipe collections, and additional cook programs that feature dishes and meal ideas that outdoor cooks can easily create with these new products. Weber owners can explore recipes for simple fare such as Balsamic Glazed Pork Chops with Peach Salsa and Grilled Carrots with Nutmeg Butter, to more sophisticated dishes such as Lemon-Ginger Tofu Steaks with Carrot and Cashew Salad or Chargrilled Oysters with Creole Remoulade Sauce and Grill Corn on the Cob with Basil Parmesan Butter.
The full 2022 GENESIS Gas Grill line and WEBER CRAFTED Outdoor Kitchen Collection will be available in the Americas and Europe leading up to the Spring barbecuing season from Weber websites and retail partners worldwide. In North America, consumers can purchase select models of the 2022 Genesis gas grill line and WEBER CRAFTED Collection online and in-store now. In addition, the 2022 SMOKEFIRE Wood Fired Pellet Grill, STEALTH Edition, will be available for purchase this Spring.
ABOUT WEBER INC.
Weber Inc. headquartered in Palatine, Ill., is the world’s leading barbecue brand. The Company’s founder George Stephen, Sr., established the outdoor cooking category when he invented the original kettle charcoal grill nearly 70 years ago. Weber offers a comprehensive, innovative product portfolio, including charcoal, gas, pellet and electric grills, smokers, and accessories designed to help outdoor cooking enthusiasts discover what’s possible. In 2021, the Company acquired June Life Inc., a smart appliance and technology company, to accelerate the development of its Weber Connect technology and digital products. In addition, Weber recently launched 1952 Ventures , a subsidiary designed to accelerate new growth platforms and brand extensions for the Company in the areas of product, technologies, and partnerships. Weber offers its barbecue grills and accessories, services, and experiences to a passionate community of millions across 78 countries.
WEBER®, GENESIS®, SMOKEFIRE®, and WEBER CONNECT® are U.S. registered trademarks; STEALTH; NIGHTVISION, PUREBLUE, and SEAR ZONE are trademarks; all owned by Weber-Stephen Products LLC.
FUTURE STATEMENTS
This press release contains various “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, which represent Weber’s expectations or beliefs concerning future events. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors listed in the Company's filings with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.
Our future results could be affected by a variety of other factors, including uncertainty of the magnitude, duration, geographic reach, impact on the global economy and current and potential travel restrictions of the COVID-19 outbreak, the current, and uncertain future, impact of the COVID-19 outbreak on our business, growth, reputation, prospects, financial condition, operating results (including components of our financial results), and cash flows and liquidity, risks relating to any unforeseen changes to or effects on liabilities, future capital expenditures, revenues, expenses, earnings, synergies, indebtedness, financial condition, losses and future prospects, the ability to realize the anticipated benefits and synergies from business acquisitions in the amounts and at the times expected, the impact of competitive conditions, the effectiveness of pricing, advertising, and promotional programs; the success of innovation, renovation and new product introductions; the recoverability of the carrying value of goodwill and other intangibles, the success of productivity improvements and business transitions, commodity and energy prices, transportation costs, labor costs, disruptions or inefficiencies in supply chain, the availability of and interest rates on short-term and long-term financing, the levels of spending on systems initiatives, properties, business opportunities, integration of acquired businesses, and other general and administrative costs, changes in consumer behavior and preferences, the effect of U.S. and foreign economic conditions on items such as interest rates, statutory tax rates, currency conversion and availability, legal and regulatory factors including the impact of any product recalls; and business disruption or other losses from war, pandemic, terrorist acts or political unrest.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220118005538/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
